Sanger sequencing of the coding sequences and exon–intron junctions of BRCA1 and BRCA2 on DNA from the blood samples of the patients who donated their breast cancer tissue for PDTX, had confirmed the absence of pathogenic germline mutations in both PDTX models (Tables S3 and S4). The gene discussed is BRCA1; the disease is breast carcinoma.